TRI-LINYAH Drug Patent Profile
✉ Email this page to a colleague
When do Tri-linyah patents expire, and what generic alternatives are available?
Tri-linyah is a drug marketed by Novast Labs Ltd and is included in one NDA.
The generic ingredient in TRI-LINYAH is ethinyl estradiol; norgestimate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRI-LINYAH?
- What are the global sales for TRI-LINYAH?
- What is Average Wholesale Price for TRI-LINYAH?
Summary for TRI-LINYAH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 735 |
| Drug Sales Revenues: | Drug sales revenues for TRI-LINYAH |
| DailyMed Link: | TRI-LINYAH at DailyMed |
US Patents and Regulatory Information for TRI-LINYAH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs Ltd | TRI-LINYAH | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090524-001 | May 30, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
